Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons
Saved in:
Main Authors: | Sueanne Chear (Author), Sharn Perry (Author), Richard Wilson (Author), Aidan Bindoff (Author), Jana Talbot (Author), Tyson L. Ware (Author), Alexandra Grubman (Author), James C. Vickers (Author), Alice Pébay (Author), Jonathan B. Ruddle (Author), Anna E. King (Author), Alex W. Hewitt (Author), Anthony L. Cook (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease
by: Samantha J. Murray, et al.
Published: (2023) -
Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder
by: Ekaterina Savchenko, et al.
Published: (2017) -
Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid
by: Malaz Yousef, et al.
Published: (2023) -
Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
by: Specchio N, et al.
Published: (2020) -
Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants
by: Zhijie Gao, et al.
Published: (2018)